ArticleCancers2023

Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study.

Mathias E Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.